Buy or sell CardioFocus stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
CardioFocus Stock
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
About CardioFocus Stock
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
Funding History
| August 1998 | $2.6M |
|---|---|
| January 2000 | $9.6M |
| August 2001 | $1.8M |
| June 2004 | $10.7M |
| June 2008 | $9.1M |
| June 2009 | $5.9M |
| February 2011 | $30.6M |
| March 2011 | $5.0M |
| May 2013 | $11.0M |
| May 2014 | $2.4M |
| January 2015 | $32.0M |
| May 2016 | $8.0M |
| March 2017 | $20.2M |
| June 2018 | $21.0M |
| May 2019 | $55.0M |
| July 2020 | $12.0M |
| April 2022 | $4.0M |
Management
CEO & Board Member
Burke T Barrett
Executive Chairman
Paul LaViolette
VP Product Devlopment
Jerry Melsky
VP of Program Management
Rebecca Anderson
Bord of Directors
Michael Wasserman
VP of Operations
Mark Casey
Vice President of Operations
Brian K. Estabrook
Board of Directors
Bruce Robertson
Board Observer
Lisa Granick
Board Director
Paul LaViolette
Director, US Sales
Christopher F. Hallett
VP Sales & Marketing
Karl Firth
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
